vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Loar Holdings Inc. (LOAR). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $131.8M, roughly 1.4× Loar Holdings Inc.). Loar Holdings Inc. runs the higher net margin — 9.5% vs 0.9%, a 8.6% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs 19.3%). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs 19.8%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
FOLD vs LOAR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $131.8M |
| Net Profit | $1.7M | $12.5M |
| Gross Margin | 85.7% | 52.1% |
| Operating Margin | 8.6% | 18.0% |
| Net Margin | 0.9% | 9.5% |
| Revenue YoY | 23.7% | 19.3% |
| Net Profit YoY | -88.5% | 239.5% |
| EPS (diluted) | $0.00 | $0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $131.8M | ||
| Q3 25 | $169.1M | $126.8M | ||
| Q2 25 | $154.7M | $123.1M | ||
| Q1 25 | $125.2M | $114.7M | ||
| Q4 24 | $149.7M | $110.4M | ||
| Q3 24 | $141.5M | $103.5M | ||
| Q2 24 | $126.7M | $97.0M | ||
| Q1 24 | $110.4M | $91.8M |
| Q4 25 | $1.7M | $12.5M | ||
| Q3 25 | $17.3M | $27.6M | ||
| Q2 25 | $-24.4M | $16.7M | ||
| Q1 25 | $-21.7M | $15.3M | ||
| Q4 24 | $14.7M | $3.7M | ||
| Q3 24 | $-6.7M | $8.7M | ||
| Q2 24 | $-15.7M | $7.6M | ||
| Q1 24 | $-48.4M | $2.2M |
| Q4 25 | 85.7% | 52.1% | ||
| Q3 25 | 88.5% | 52.7% | ||
| Q2 25 | 90.2% | 53.8% | ||
| Q1 25 | 90.7% | 52.1% | ||
| Q4 24 | 90.1% | 48.9% | ||
| Q3 24 | 90.6% | 51.1% | ||
| Q2 24 | 91.1% | 49.0% | ||
| Q1 24 | 87.7% | 48.4% |
| Q4 25 | 8.6% | 18.0% | ||
| Q3 25 | 20.3% | 22.9% | ||
| Q2 25 | -6.1% | 22.2% | ||
| Q1 25 | -6.3% | 22.8% | ||
| Q4 24 | 10.7% | 19.2% | ||
| Q3 24 | 15.3% | 22.1% | ||
| Q2 24 | 11.8% | 22.9% | ||
| Q1 24 | -25.1% | 23.3% |
| Q4 25 | 0.9% | 9.5% | ||
| Q3 25 | 10.2% | 21.8% | ||
| Q2 25 | -15.8% | 13.6% | ||
| Q1 25 | -17.3% | 13.4% | ||
| Q4 24 | 9.8% | 3.3% | ||
| Q3 24 | -4.8% | 8.4% | ||
| Q2 24 | -12.4% | 7.9% | ||
| Q1 24 | -43.9% | 2.4% |
| Q4 25 | $0.00 | $0.13 | ||
| Q3 25 | $0.06 | $0.29 | ||
| Q2 25 | $-0.08 | $0.17 | ||
| Q1 25 | $-0.07 | $0.16 | ||
| Q4 24 | $0.05 | $-11023.48 | ||
| Q3 24 | $-0.02 | $0.09 | ||
| Q2 24 | $-0.05 | $0.09 | ||
| Q1 24 | $-0.16 | $11023.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $84.8M |
| Total DebtLower is stronger | $392.7M | $715.7M |
| Stockholders' EquityBook value | $274.2M | $1.2B |
| Total Assets | $949.9M | $2.0B |
| Debt / EquityLower = less leverage | 1.43× | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $84.8M | ||
| Q3 25 | $263.8M | $99.0M | ||
| Q2 25 | $231.0M | $103.3M | ||
| Q1 25 | $250.6M | $80.5M | ||
| Q4 24 | $249.9M | $54.1M | ||
| Q3 24 | $249.8M | $55.2M | ||
| Q2 24 | $260.1M | $73.2M | ||
| Q1 24 | $239.6M | $28.2M |
| Q4 25 | $392.7M | $715.7M | ||
| Q3 25 | $392.0M | $279.4M | ||
| Q2 25 | $391.3M | $277.7M | ||
| Q1 25 | $390.7M | $277.5M | ||
| Q4 24 | $390.1M | $277.3M | ||
| Q3 24 | $389.5M | $602.1M | ||
| Q2 24 | $388.9M | $250.7M | ||
| Q1 24 | $388.4M | $534.2M |
| Q4 25 | $274.2M | $1.2B | ||
| Q3 25 | $230.4M | $1.2B | ||
| Q2 25 | $204.3M | $1.1B | ||
| Q1 25 | $193.6M | $1.1B | ||
| Q4 24 | $194.0M | $1.1B | ||
| Q3 24 | $178.8M | $769.8M | ||
| Q2 24 | $132.5M | $758.4M | ||
| Q1 24 | $130.7M | $420.6M |
| Q4 25 | $949.9M | $2.0B | ||
| Q3 25 | $868.8M | $1.5B | ||
| Q2 25 | $815.3M | $1.5B | ||
| Q1 25 | $789.8M | $1.5B | ||
| Q4 24 | $785.0M | $1.5B | ||
| Q3 24 | $786.6M | $1.5B | ||
| Q2 24 | $749.5M | $1.1B | ||
| Q1 24 | $721.8M | $1.1B |
| Q4 25 | 1.43× | 0.61× | ||
| Q3 25 | 1.70× | 0.24× | ||
| Q2 25 | 1.92× | 0.25× | ||
| Q1 25 | 2.02× | 0.25× | ||
| Q4 24 | 2.01× | 0.25× | ||
| Q3 24 | 2.18× | 0.78× | ||
| Q2 24 | 2.93× | 0.33× | ||
| Q1 24 | 2.97× | 1.27× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $30.4M |
| Free Cash FlowOCF − Capex | $16.0M | — |
| FCF MarginFCF / Revenue | 8.6% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | 9.62× | 2.43× |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $30.4M | ||
| Q3 25 | $35.7M | $29.7M | ||
| Q2 25 | $-26.5M | $23.8M | ||
| Q1 25 | $7.8M | $28.4M | ||
| Q4 24 | $-3.9M | $20.7M | ||
| Q3 24 | $-23.0M | $16.3M | ||
| Q2 24 | $22.7M | $7.1M | ||
| Q1 24 | $-29.7M | $10.8M |
| Q4 25 | $16.0M | — | ||
| Q3 25 | $35.3M | — | ||
| Q2 25 | $-28.9M | — | ||
| Q1 25 | $7.5M | — | ||
| Q4 24 | $-4.2M | — | ||
| Q3 24 | $-23.3M | — | ||
| Q2 24 | $21.6M | — | ||
| Q1 24 | $-31.5M | — |
| Q4 25 | 8.6% | — | ||
| Q3 25 | 20.9% | — | ||
| Q2 25 | -18.7% | — | ||
| Q1 25 | 6.0% | — | ||
| Q4 24 | -2.8% | — | ||
| Q3 24 | -16.5% | — | ||
| Q2 24 | 17.0% | — | ||
| Q1 24 | -28.5% | — |
| Q4 25 | 0.2% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 1.6% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.9% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 9.62× | 2.43× | ||
| Q3 25 | 2.06× | 1.08× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | — | 1.85× | ||
| Q4 24 | -0.27× | 5.62× | ||
| Q3 24 | — | 1.89× | ||
| Q2 24 | — | 0.93× | ||
| Q1 24 | — | 4.81× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
LOAR
| Other | $76.8M | 58% |
| Commercial Aerospace | $21.2M | 16% |
| Business Jet And General Aviation | $17.6M | 13% |
| Defense | $16.2M | 12% |
